Le Lézard
Classified in: Business
Subject: STH

IIROC Trading Halt - ITV


VANCOUVER, July 15, 2019 /CNW/ - The following issues have been halted by IIROC:

Company:  ICTV Brands Inc.

CSE Symbol: ITV (All Issues)

Reason:  Failure to Maintain Exchange Requirements

Halt Time (ET): 15:16 PM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions


These press releases may also interest you

at 18:15
Americas Gold and Silver Corporation ("Americas" or the "Company"), a growing North American precious metals producer, reports consolidated financial and operational results for the year ended December 31, 2023. This earnings release should be...

at 18:15
Westhaven Gold Corp. is pleased to announce that it has closed the final tranche of the non-brokered private placement announced on February 20, 2024. Westhaven has issued a total of 7,926,182 common shares that qualify as "flow-through shares" of...

at 18:03
Revenue Revenue for the year was $238.5, down $1.4 from sales of $239.9 in 2022. The Company's  sales were flat when compared to 2022 and 2021 included a fifteen month period due to the accounting change from September 30 to December 31. Twelve-month...

at 18:02
Buhler Industries Inc. ("Buhler Industries or the Company"), the manufacturer of Versatile and Farm King brands of farm equipment, has made operational restructuring changes in the first quarter of 2024 that is expected to result in significant full...

at 18:01
Buhler Versatile Inc. ("Versatile"), a wholly owned subsidiary of Buhler Industries Inc. (Buhler Industries or the Company), has received $14.4 million Canadian ($10.7 million USD) in additional long term financing from its majority owner Ba?ak...

at 18:00
Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a research collaboration with Dr. Jessica M. Konen's Lab at Emory University School of Medicine....



News published on and distributed by: